Follow
Amit Sud
Amit Sud
Dana-Farber Cancer Institute and University of Oxford
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
A Sud, ME Jones, J Broggio, C Loveday, B Torr, A Garrett, DL Nicol, ...
Annals of Oncology 31 (8), 1065-1074, 2020
6042020
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
A Sud, B Torr, ME Jones, J Broggio, S Scott, C Loveday, A Garrett, ...
The Lancet Oncology 21 (8), 1035-1044, 2020
5102020
Genome-wide association studies of cancer: current insights and future perspectives
A Sud, B Kinnersley, RS Houlston
Nature Reviews Cancer 17 (11), 692-704, 2017
3972017
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ...
Nature communications 10 (1), 2154, 2019
2252019
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
S Bird, A Panopoulou, RL Shea, M Tsui, R Saso, A Sud, S West, K Smith, ...
The Lancet Haematology 8 (6), e389-e392, 2021
1452021
Cancer genetics, precision prevention and a call to action
C Turnbull, A Sud, RS Houlston
Nature genetics 50 (9), 1212-1218, 2018
1352018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ...
Nature communications 9 (1), 3707, 2018
1252018
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1
D Hanson, PG Murray, A Sud, SA Temtamy, M Aglan, A Superti-Furga, ...
The American Journal of Human Genetics 84 (6), 801-806, 2009
1092009
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis
S May-Wilson, A Sud, PJ Law, K Palin, S Tuupanen, A Gylfe, ...
European Journal of Cancer 84, 228-238, 2017
1072017
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study
C Loveday, A Sud, ME Jones, J Broggio, S Scott, F Gronthound, B Torr, ...
Gut 70 (6), 1053-1060, 2021
97*2021
Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer
H Rodriguez‐Broadbent, PJ Law, A Sud, K Palin, S Tuupanen, A Gylfe, ...
International journal of cancer 140 (12), 2701-2708, 2017
882017
Risk of second cancer in Hodgkin lymphoma survivors and influence of family history
A Sud, H Thomsen, K Sundquist, RS Houlston, K Hemminki
Journal of Clinical Oncology 35 (14), 1584-1590, 2017
842017
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
A Sud, S Chattopadhyay, H Thomsen, K Sundquist, J Sundquist, ...
Blood, The Journal of the American Society of Hematology 134 (12), 960-969, 2019
812019
Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling
D Hanson, PG Murray, T Coulson, A Sud, A Omokanye, E Stratta, ...
Journal of molecular endocrinology 49 (3), 267, 2012
722012
Impact of atopy on risk of glioma: a Mendelian randomisation study
L Disney-Hogg, AJ Cornish, A Sud, PJ Law, B Kinnersley, DI Jacobs, ...
BMC medicine 16, 1-13, 2018
562018
Will polygenic risk scores for cancer ever be clinically useful?
A Sud, C Turnbull, R Houlston
Npj Precision Oncology 5 (1), 40, 2021
552021
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
A Sud, H Thomsen, PJ Law, A Försti, MI da Silva Filho, A Holroyd, ...
Nature communications 8 (1), 1892, 2017
522017
Realistic expectations are key to realising the benefits of polygenic scores
A Sud, RH Horton, AD Hingorani, I Tzoulaki, C Turnbull, RS Houlston, ...
Bmj 380, 2023
482023
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
G Zheng, S Chattopadhyay, A Sud, K Sundquist, J Sundquist, A Försti, ...
British Journal of Haematology, 2019
482019
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases
K Hemminki, A Försti, R Houlston, A Sud
International Journal of Cancer, 2021
462021
The system can't perform the operation now. Try again later.
Articles 1–20